At Northeastern’s Antimicrobial Discovery Center, research on how the bacterium that causes Lyme disease evades antibiotics is conducted by Dr. Kim Lewis and his team.
On Friday, March 18, faculty and staff of Northeastern’s Biotechnology Programs welcomed a delegation of 18 professors, physician’s and research fellows from Anhui Province in China. The group spent time in New Jersey and Massachusetts visiting a variety of sites in order to learn about the U.S. biotechnology industry. The delegation wanted to visit Northeastern in order […]
Northeastern moves into top tier for research activity among higher ed institutions
Throughout Northeastern’s School of Pharmacy, researchers are making progress in solving a range of pressing health challenges.
Dr. Murthy’s research focuses on designing microfluidic devices for applications in clinical diagnostics and medicine.
Antarctic fish are a vital component to the food web that sustains life in the cold Southern Ocean that surrounds Antarctica.
The bacterium that causes Lyme disease forms dormant persister cells, which are known to evade antibiotics.
Northeastern Professors Kim Lewis and Slava Epstein garner world-wide attention with their iChip-the most promising new antibiotic in decades.
“Breathing supplemental oxygen opens up the gates of the tumor fortress and wakes up ‘sleepy’ anti-tumor cells, enabling these soldiers to enter the fortress and destroy it,”Dr. Sitkovsky explains.
Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.